Johan Lundberg

Om mig
Publikationer
Forskningsbidrag
CV
Populärvetenskap och samverkan

Om mig

Adjungerad professor i psykiatri vid institutionen för klinisk
neurovetenskap från 1 februari 2022.
Primär anställning: Vårdprocessansvarig överläkare och chef för
Sektionen för affektiva sjukdomar, Norra Stockholms psykiatri
Forskargruppsledare, se länken nedan.

Artiklar

Article: JOURNAL OF AFFECTIVE DISORDERS. 2024;362:96-103
Association between neighborhood socioeconomic status and healthcare utilization among individuals with a first diagnosis of major depressive disorder in primary care in the Stockholm region
Gannedahl A; Bjorkholm C; Leval A; Cars T; Hellner C; Lundberg J
Article: JAMA PSYCHIATRY. 2024;81(9):863-869
Adolescent and Adult Transitions From Major Depressive Disorder to Bipolar Disorder
Bostrom AED; Cars T; Hellner C; Lundberg J
Article: JAMA NETWORK OPEN. 2024;7(7):e2422738
Seizure Duration and Electroconvulsive Therapy in Major Depressive Disorder
Gillving C; Ekman CJ; Hammar A; Landen M; Lundberg J; Rad PM; Nordanskog P; von Knorring L; Nordenskjold A
Article: JOURNAL OF ECT. 2024;40(2):88-95
Electroconvulsive Therapy Versus Repetitive Transcranial Magnetic Stimulation in Patients With a Depressive Episode
Strandberg P; Nordenskjold A; Boden R; Ekman CJ; Lundberg J; Popiolek K
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2024;27(5):pyae021
Altered Serotonin 1B Receptor Binding After Escitalopram for Depression Is Correlated With Treatment Effect
Garde M; Matheson GJ; Varnaes K; Svenningsson P; Hedman-Lagerloef E; Lundberg J; Farde L; Tiger M
Article: SCHIZOPHRENIA. 2024;10(1):5
Challenges and opportunities in the diagnosis and treatment of early-onset psychosis: a case series from the youth affective disorders clinic in Stockholm, Sweden
Lundberg M; Andersson P; Lundberg J; Bostrom AED
Journal article: NEUROSCIENCE APPLIED. 2024;3:103929
Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms
McCulloch DE-W; Lopez JP; Dalla C; Castrén E; Erritzoe D; Frokjaer VG; Lundberg J; Preller KH; Fisher PM; Knudsen GM
Journal article: NEUROSCIENCE APPLIED. 2024;3:103938
Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects
McCulloch DE-W; Liechti ME; Kuypers KP; Nutt D; Lundberg J; Stenbæk DS; Goodwin GM; Gründer G; Butlen-Ducuing F; Haberkamp M; Thirstrup S; Knudsen GM
Article: INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH. 2023;32(4):e1960
Mapping length of inpatient treatment duration and year-wise relapse rates in eating disordered populations in a well-defined Western-European healthcare region across 1998-2020
Andersson P; Jamshidi E; Ekman C-J; Tedroff K; Bjorkander J; Sjogren M; Lundberg J; Jokinen J; Bostrom ADE
Article: JAMA PSYCHIATRY. 2023;80(12):1218-1225
Determinants and Outcomes of Suicidal Behavior Among Patients With Major Depressive Disorder
Lundberg J; Cars T; Lampa E; Ekholm Selling K; Leval A; Gannedahl A; Sjaelin M; Bjoerkholm C; Hellner C
Article: JOURNAL OF ECT. 2023;39(4):227-234
Anorexia Nervosa With Comorbid Severe Depression
Andersson P; Jamshidi E; Ekman C-J; Tedroff K; Bjorkander J; Sjogren M; Lundberg J; Jokinen J; Desai Bostrom AE
Article: BRAIN, BEHAVIOR, & IMMUNITY - HEALTH. 2023;31:100665
Inverse association of anti-inflammatory prescription fills and suicide-related mortality in young adults: Evidence from a nationwide study of Swedish regions, 2006-2021
Andersson P; Lundberg J; Jarbin H; Jokinen J; Bostrom AED
Article: JAMA PSYCHIATRY. 2023;80(8):796-802
Association of Bipolar Disorder Diagnosis With Suicide Mortality Rates in Adolescents in Sweden
Andersson P; Jokinen J; Jarbin H; Lundberg J; Desai Bostroem AE
Article: JOURNAL OF AFFECTIVE DISORDERS. 2023;329:50-54
Outcome of transcranial magnetic intermittent theta-burst stimulation in the treatment of depression-A Swedish register-based study
Ekman CJ; Popiolek K; Boden R; Nordenskjold A; Lundberg J
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2023;26(4):241-248
Associations Between Cognition and Serotonin 1B Receptor Availability in Healthy Volunteers: A [¹¹C]AZ10419369 Positron Emission Tomography Study
Tangen A; Veldman ER; Svensson J; Tiger M; Nord M; Sorjonen K; Andersson M; Plaven-Sigray P; Varrone A; Halldin C; Varnas K; Borg J; Lundberg J
Article: NATURE COMMUNICATIONS. 2023;14(1):1281
Regional clozapine, ECT and lithium usage inversely associated with excess suicide rates in male adolescents
Bostrom AED; Andersson P; Rask-Andersen M; Jarbin H; Lundberg J; Jokinen J
Article: JAMA PSYCHIATRY. 2023;80(2):167-175
Association of Treatment-Resistant Depression With Patient Outcomes and Health Care Resource Utilization in a Population-Wide Study
Lundberg J; Cars T; Loeoev S-A; Soederling J; Sundstroem J; Tiihonen J; Leval A; Gannedahl A; Bjoerkholm C; Sjaelin M; Hellner C
Journal article: BRAIN STIMULATION. 2023;16(1):385-386
Outcome of transcranial magnetic intermittent theta-burst stimulation in the treatment of depression - a Swedish register-based study
Ekman CJ; Popiolek K; Bodén R; Nordenskjöld A; Lundberg J
Journal article: NEUROSCIENCE APPLIED. 2023;2:101035
Glutamate 5 receptor availability differences in twins discordant for autism and controls, do shared genetics matter
Griffioen G; Andersson M; Tangen Ä; Bolin M; Farde L; Halldin C; Bölte S; Lundberg J; Borg J
Article: MOLECULAR PSYCHIATRY. 2022;27(12):5096-5112
International pooled patient-level meta-analysis of ketamine infusion for depression: In search of clinical moderators
Price RB; Kissel N; Baumeister A; Rohac R; Woody ML; Ballard ED; Zarate CAJ; Deakin W; Abdallah CG; Feder A; Charney DS; Grunebaum MF; Mann JJ; Mathew SJ; Gallagher B; McLoughlin DM; Murrough JW; Muthukumaraswamy S; McMillan R; Sumner R; Papakostas G; Fava M; Hock R; Phillips JL; Blier P; Shiroma P; Sos P; Su T-P; Chen M-H; Tiger M; Lundberg J; Wilkinson ST; Wallace ML
Article: NEUROPSYCHOPHARMACOLOGY. 2022;47(10):1863-1868
In vivo correlation of serotonin transporter and 1B receptor availability in the human brain: a PET study
Svensson JE; Tiger M; Plaven-Sigray P; Halldin C; Schain M; Lundberg J
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2022;146(1):51-63
Clinical and societal burden of incident major depressive disorder: A population-wide cohort study in Stockholm
Lundberg J; Cars T; Loov S-A; Soderling J; Tiihonen J; Leval A; Gannedahl A; Bjorkholm C; Sjalin M; Hellner C
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2022;146(1):74-84
Suicidal ideation and ECT, ECT and suicidal ideation: A register study
Sienaert P; Brus O; Lambrichts S; Lundberg J; Nordanskog P; Obbels J; Verspecht S; Vansteelandt K; Nordenskjold A
Article: TRANSLATIONAL PSYCHIATRY. 2022;12(1):226
Patterns of activity correlate with symptom severity in major depressive disorder patients
Spulber S; Elberling F; Svensson J; Tiger M; Ceccatelli S; Lundberg J
Article: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2022;42(4):630-641
Serotonin 1B receptor density mapping of the human brainstem using positron emission tomography and autoradiography
Veldman ER; Varrone A; Varnas K; Svedberg MM; Cselenyi Z; Tiger M; Gulyas B; Halldin C; Lundberg J
Article: NORDIC JOURNAL OF PSYCHIATRY. 2022;76(2):96-103
Validity of diagnoses, treatment dates, and rating scales in the Swedish national quality register for electroconvulsive therapy
Ahmad I; Sandberg M; Brus O; Ekman CJ; Hammar A; Landen M; Lundberg J; Nordanskog P; von Knorring L; Nordenskjold A
Journal article: NEUROSCIENCE APPLIED. 2022;1:100492
The cognitive effects of ketamine for SSRI-resistant depression in relation to serotonin 1B receptor binding
Tiger M; Veldman E; Lundeberg M; Tangen Ä; Ekman CJ; Lundberg J
Article: NPJ MENT HEALTH RES. 2022;1(1):13
Youth with severe mental illness and complex non-somatic motor abnormalities: conflicting conceptualizations and unequal treatment.
Andersson P; Wachtel LE; Lundberg J; Jamshidi E; Bring J; Rask-Andersen M; Jarbin H; Jokinen J; Desai Boström AE
Journal article: NEUROSCIENCE APPLIED. 2022;1:100179
Treatment resistant depression: epidemiology and consequences – a population wide study
Lundberg J; Cars T; Lööv SÅ; Söderling J; Sundström J; Leval A; Gannedahl A; Björkholm C; Själin M; Hellner C
Article: JOURNAL OF AFFECTIVE DISORDERS. 2021;290:240-244
P11 (S100A10) as a potential predictor of ketamine response in patients with SSRI-resistant depression
Veldman ER; Mamula D; Jiang H; Tiger M; Ekman C-J; Lundberg J; Svenningsson P
Article: TRANSLATIONAL PSYCHIATRY. 2021;11(1):264
Serotonin transporter availability increases in patients recovering from a depressive episode
Svensson JE; Svanborg C; Plaven-Sigray P; Kaldo V; Halldin C; Schain M; Lundberg J
Article: MOLECULAR PSYCHIATRY. 2021;26(5):1647-1658
Serotonin transporter availability in adults with autism-a positron emission tomography study
Andersson M; Tangen A; Farde L; Bolte S; Halldin C; Borg J; Lundberg J
Article: MEDICINE. 2021;100(14):e25273
Repetitive transcranial magnetic stimulation in major depression A three-arm parallel-group dose-response randomized pilot trial
Johansson K; Adler M; Bave U; Ekman C-J; Lundberg J
Article: NORDIC JOURNAL OF PSYCHIATRY. 2021;75(3):201-206
Relapse risk after in-ward electroconvulsive therapy for acute polymorphic psychotic disorder
Kalling S; Brus O; Landen M; Lundberg J; Nordanskog P; Nordenskjold A
Article: NEUROIMAGE. 2021;226:117523
Low convergent validity of [¹¹C]raclopride binding in extrastriatal brain regions: A PET study of within-subject correlations with [¹¹C]FLB 457
Freiburghaus T; Svensson JE; Matheson GJ; Plaven-Sigray P; Lundberg J; Farde L; Cervenka S
Article: FRONTIERS IN NEUROSCIENCE. 2021;15:698633
Plasma Levels of Brain-Derived Neurotrophic Factor and S100B in Relation to Antidepressant Response to Ketamine
Jiang H; Veldman ER; Tiger M; Ekman C-J; Lundberg J; Svenningsson P
Article: JOURNAL OF ECT. 2020;36(4):272-278
The Effect of Pulse Width on Subjective Memory Impairment and Remission Rate 6 Months After Electroconvulsive Therapy
Tornhamre E; Ekman CJ; Hammar A; Landen M; Lundberg J; Nordanskog P; Nordenskjold A
Article: JOURNAL OF ECT. 2020;36(4):242-246
Electroconvulsive Therapy in Depression Improvement in Quality of Life Depending on Age and Sex
Guney P; Ekman CJ; Hammar A; Heintz E; Landen M; Lundberg J; Nordanskog P; Nordenskjold A
Article: JOURNAL OF ECT. 2020;36(3):168-171
The Incidence of Dental Fracturing in Electroconvulsive Therapy in Sweden
Goeterfelt L; Ekman CJ; Hammar A; Landen M; Lundberg J; Nordanskog P; Nordenskjoeld A
Article: NORDIC JOURNAL OF PSYCHIATRY. 2020;74(5):359-365
Physician estimated vs. self-reported subjective memory in depressed patients treated with electroconvulsive therapy
Stengard J; Ekman CJ; Bave U; Lundahl A; Abawi M; Adler M; Landen M; Lundberg J
Article: TRANSLATIONAL PSYCHIATRY. 2020;10(1):159
A randomized placebo-controlled PET study of ketamine′s effect on serotonin_1B receptor binding in patients with SSRI-resistant depression
Tiger M; Veldman ER; Ekman C-J; Halldin C; Svenningsson P; Lundberg J
Article: PSYCHIATRY AND CLINICAL NEUROSCIENCES. 2020;74(4):263-269
[¹¹C]raclopride positron emission tomography study of dopamine-D_2/3 receptor binding in patients with severe major depressive episodes before and after electroconvulsive therapy and compared to control subjects
Tiger M; Svensson J; Liberg B; Saijo T; Schain M; Halldin C; Farde L; Lundberg J
Journal article: SCHIZOPHRENIA BULLETIN OPEN. 2020;1(1):sgaa019
Predictors of Treatment Response to Electroconvulsive Therapy in Schizophrenia—A Nationwide Registry-Based Study
Stenmark L; Popiolek K; Bodén R; Brus O; Hammar Å; Landén M; Lundberg J; Nordanskog P; Nordenskjöld A
Article: JOURNAL OF ECT. 2019;35(4):264-271
Rehospitalization of Postpartum Depression and Psychosis After Electroconvulsive Therapy A Population-Based Study With a Matched Control Group
Ronnqvist I; Brus O; Hammar A; Landen M; Lundberg J; Nordanskog P; Nordenskjold A
Article: NEUROIMAGE. 2019;202:116143
Validity and reliability of extrastriatal [¹¹C]raclopride binding quantification in the living human brain
Svensson JE; Schain M; Plaven-Sigray P; Cervenka S; Tiger M; Nord M; Halldin C; Farde L; Lundberg J
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2019;140(3):196-204
Electroconvulsive therapy in bipolar depression - effectiveness and prognostic factors
Popiolek K; Beierot S; Brus O; Hammer A; Leaden M; Lundberg J; Nordanskog P; Nordenskjold A
Article: BJPSYCH OPEN. 2019;5(3):e46
Lithium for suicide and readmission prevention after electroconvulsive therapy for unipolar depression: population-based register study
Brus O; Cao Y; Hammar A; Landen M; Lundberg J; Nordanskog P; Nordenskjold A
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2019;22(4):278-285
Venlafaxine ER Blocks the Norepinephrine Transporter in the Brain of Patients with Major Depressive Disorder: a PET Study Using [¹⁸F]FMeNER-D₂
Arakawa R; Stenkrona P; Takano A; Svensson J; Andersson M; Nag S; Asami Y; Hirano Y; Halldin C; Lundberg J
Article: SCIENCE TRANSLATIONAL MEDICINE. 2018;10(461):eaam8434
GABA_A receptor availability is not altered in adults with autism spectrum disorder or in mouse models
Horder J; Andersson M; Mendez MA; Singh N; Tangen A; Lundberg J; Gee A; Halldin C; Veronese M; Bolte S; Farde L; Sementa T; Cash D; Higgins K; Spain D; Turkheimer F; Mick I; Selvaraj S; Nutt DJ; Lingford-Hughes A; Howes OD; Murphy DG; Borg J
Article: JOURNAL OF AFFECTIVE DISORDERS. 2018;235:258-264
Improvement of postpartum depression and psychosis after electroconvulsive therapy: A population-based study with a matched comparison group
Rundgren S; Brus O; Bave U; Landen M; Lundberg J; Nordanskog P; Nordenskjold A
Article: JOURNAL OF AFFECTIVE DISORDERS. 2018;226:146-154
Rehospitalization and suicide following electroconvulsive therapy for bipolar depression-A population-based register study
Popiolek K; Brus O; Elvin T; Landen M; Lundberg J; Nordanskog P; Nordenskjold A
Article: PSYCHIATRY RESEARCH-NEUROIMAGING. 2017;267:15-21
Associations between cognition and serotonin receptor 1B binding in patients with major depressive disorder - A pilot study.
Tangen Ä; Borg J; Tiger M; Varnäs K; Sorjonen K; Lindefors N; Halldin C; Lundberg J
Article: EUROPEAN PSYCHIATRY. 2017;45:154-160
Self-assessed remission rates after electroconvulsive therapy of depressive disorders
Brus O; Cao Y; Gustafsson E; Hulten M; Landen M; Lundberg J; Nordanskog P; Nordenskjold A
Article: NORDIC JOURNAL OF PSYCHIATRY. 2017;71(6):405-410
Improvement of cycloid psychosis following electroconvulsive therapy
Holm J; Brus O; Bave U; Landen M; Lundberg J; Nordanskog P; von Knorring L; Nordenskjold A
Article: JOURNAL OF ECT. 2017;33(2):96-103
Subjective Memory Immediately Following Electroconvulsive Therapy
Brus O; Nordanskog P; Bave U; Cao Y; Hammar A; Landen M; Lundberg J; Nordenskjold A
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2017;27(5):504-514
Distribution and levels of 5-HT_1B receptors in anterior cingulate cortex of patients with bipolar disorder, major depressive disorder and schizophrenia - An autoradiography study
Veldman ER; Svedberg MM; Svenningsson P; Lundberg J
Article: PSYCHIATRY RESEARCH-NEUROIMAGING. 2016;253:36-42
Low serotonin_1B receptor binding potential in the anterior cingulate cortex in drug-free patients with recurrent major depressive disorder
Tiger M; Farde L; Ruck C; Varrone A; Forsberg A; Lindefors N; Halldin C; Lundberg J
Article: JOURNAL OF ECT. 2015;31(4):263-267
Electroconvulsive Therapy in Sweden 2013 Data From the National Quality Register for ECT
Nordanskog P; Hulten M; Landen M; Lundberg J; von Knorring L; Nordenskjold A
Article: NEUROIMAGE. 2015;112:225-231
Diurnal and seasonal variation of the brain serotonin system in healthy male subjects
Matheson GJ; Schain M; Almeida R; Lundberg J; Cselenyi Z; Borg J; Varrone A; Farde L; Cervenka S
Article: NEUROIMAGE. 2014;103:303-308
Distinct regional age effects on [¹¹C]AZ10419369 binding to 5-HT_1B receptors in the human brain
Nord M; Cselenyi Z; Forsberg A; Rosenqvist G; Tiger M; Lundberg J; Varrone A; Farde L
Article: SYNAPSE. 2014;68(10):480-483
No correlation between serotonin and its metabolite 5-HIAA in the cerebrospinal fluid and [(11) C]AZ10419369 binding measured with PET in healthy volunteers.
Tiger M; Svenningsson P; Nord M; Jabre S; Halldin C; Lundberg J
Article: PSYCHIATRY RESEARCH. 2014;223(2):164-170
Reduced 5-HT_1B receptor binding in the dorsal brain stem after cognitive behavioural therapy of major depressive disorder
Tiger M; Ruck C; Forsberg A; Varrone A; Lindefors N; Halldin C; Farde L; Lundberg J
Article: FRONTIERS IN PSYCHIATRY. 2014;5:176
Functional and structural alterations in the cingulate motor area relate to decreased fronto-striatal coupling in major depressive disorder with psychomotor disturbances
Liberg B; Klauser P; Harding IH; Adler M; Rahm C; Lundberg J; Masterman T; Wachtler C; Jonsson T; Kristoffersen-Wiberg M; Pantelis C; Wahlund B
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2013;23(10):1190-1198
5-HTT and 5-HT_1A receptor occupancy of the novel substance vortioxetine (Lu AA21004). A PET study in control subjects
Stenkrona P; Halldin C; Lundberg J
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2012;15(8):1167-1172
Serotonin transporter occupancy with TCAs and SSRIs: a PET study in patients with major depressive disorder
Lundberg J; Tiger M; Landen M; Halldin C; Farde L
Article: BIOLOGICAL PSYCHIATRY. 2009;66(5):477-485
Genetic Variation in Brain-Derived Neurotrophic Factor Is Associated with Serotonin Transporter but Not Serotonin-1A Receptor Availability in Men
Henningsson S; Borg J; Lundberg J; Bah J; Lindstrom M; Ryding E; Jovanovic H; Saijo T; Inoue M; Rosen I; Traskman-Bendz L; Farde L; Eriksson E
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2009;12(6):783-792
Serotonin transporter genotype is associated with cognitive performance but not regional 5-HT_1A receptor binding in humans
Borg J; Henningsson S; Saijo T; Inoue M; Bah J; Westberg L; Lundberg J; Jovanovic H; Andree B; Nordstrom A-L; Halldin C; Eriksson E; Farde L
Article: NEUROIMAGE. 2008;39(3):1408-1419
Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET
Jovanovic H; Lundberg J; Karlsson P; Cerin A; Saijo T; Varrone A; Halldin C; Nordstrom A-L
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2007;10(6):777-785
PET measurement of serotonin transporter occupancy: a comparison of escitalopram and citalopram
Lundberg J; Christophersen JS; Petersen KB; Loft H; Halldin C; Farde L
Article: PSYCHOPHARMACOLOGY. 2007;195(3):425-433
A PET study on regional coexpression of 5-HT_1A receptors and 5-HTT in the human brain
Lundberg J; Borg J; Halldin C; Farde L
Article: LAKARTIDNINGEN. 2007;104(26-27):2002-2003
[Coming generation of researchers--a question of fate for psychiatry].
Cervenka S; Reutfors J; Lundberg J; Papadopoulos F; Lundén E; Sjöström C; Björklund L
Article: PSYCHIATRY RESEARCH. 2006;148(2-3):185-193
A PET study of 5-HT_1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoria
Jovanovic H; Cerin A; Karlsson P; Lundberg J; Halldin C; Nordstrom A-L
Article: SYNAPSE. 2006;60(3):256-263
Measurement of serotonin transporter binding with PET and [¹¹C]MADAM:: A test-retest reproducibility study
Lundberg J; Halldin C; Farde L
Article: PSYCHOPHARMACOLOGY. 2006;185(3):389-394
Search for correlations between serotonin 5-HT_1A receptor expression and cognitive functions -: a strategy in translational psychopharmacology
Borg J; Andrée B; Lundberg J; Halldin C; Farde L
Article: SYNAPSE. 2005;58(3):173-183
[¹¹C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PET
Halldin C; Lundberg J; Sóvágó J; Gulyás B; Guilloteau D; Vercouillie J; Emond P; Chalon S; Tarkiainen J; Hiltunen J; Farde L
Article: JOURNAL OF NUCLEAR MEDICINE. 2005;46(9):1505-1515
Quantification of ¹¹C-MADAM binding to the serotonin transporter in the human brain
Lundberg J; Odano I; Olsson H; Halldin C; Farde L
Article: NEUROCHEMISTRY INTERNATIONAL. 2004;45(5):773-781
Joint explorative analysis of neuroreceptor subsystems in the human brain:: application to receptor-transporter correlation using PET data
Cselényi Z; Lundberg J; Halldin C; Farde L; Gulyás B
Visa fler

Alla övriga publikationer

Letter: JOURNAL OF ECT. 2024;40(2):140-141
Electroconvulsive Therapy Versus Repetitive Transcranial Magnetic Stimulation in Patients With a Depressive Episode: A Register-Based Study
Popiolek K; Arnison T; Boden R; Ekman CJ; Lundberg J; Strandberg P; Nordenskjold A
Review: LAKARTIDNINGEN. 2024;121:23195
[Psychedelic psychiatry].
López E; Yngwe H; Beckman M; Tiger M; Hieronymus F; Lundberg J
Review: TRANSLATIONAL PSYCHIATRY. 2024;14(1):175
Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic
Tiger M; Castelpietra G; Wesselhoeft R; Lundberg J; Reutfors J
Letter: JAMA PSYCHIATRY. 2024;81(4):426
Antidepressant Use and Manic Episodes in Children and Adolescents With Unipolar Depression
Bostroem AED; Andersson P; Lundberg J
Letter: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2023;82(19):E177
Beyond the Surface Scrutinizing Methodological Biases in a Study on iCBT for Atrial Fibrillation
Bostrom AED; Lundberg J
Preprint: MEDRXIV. 2023
Correlations between patterns of activity and the response to treatment yield distinct signatures for different antidepressive treatments
Spulber S; Elberling F; Ceccatelli S; Gärde M; Tiger M; Lundberg J
Editorial comment: LANCET. 2023;401(10378):714-716
The therapeutic potential of psychedelics: the European regulatory perspective
Butlen-Ducuing F; McCulloch DE-W; Haberkamp M; Mattila T; Balkowiec-Iskra E; Aislaitner G; Balabanov P; Lundberg J; Stenbaek DS; Elferink A; Knudsen GM; Thirstrup S
Conference publication: PROCEEDINGS OF THE INTERNATIONAL SOCIETY FOR MAGNETIC RESONANCE IN MEDICINE ... SCIENTIFIC MEETING AND EXHIBITION.. 2022
Ketamine Induced Glutamate Alternations in Treatment-Resistant Depression. A 1H-MRS randomised placebo controlled study.
Sitnikov R; Tiger M; Lundberg J
Book chapter: TRANSLATIONAL RESEARCH METHODS FOR MAJOR DEPRESSIVE DISORDER: NEUROMETHODS. 2022;p. 227-240
Molecular Imaging of Major Depressive Disorder with Positron Emission Tomography: Translational Implications for Neurobiology and Treatment
Tiger M; Lundberg J
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2021;53:S636-S637
Epidemiology of major depression and intentional self-harm from a total-population cohort in the greater Stockholm region
Bjorkholm C; Gannedahl A; Leval A; Cars T; Sjalin M; Hellner C; Lundberg J
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2021;41(1_SUPPL):169-170
Centrum semiovale as reference region - An evaluation of methods to quantify [18F]FPEB PET binding data in man
Andersson M; Varnas K; Halldin C; Borg J; Farde L; Lundberg J
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2020;40:S149-S150
Outcome of treatment in clinical practice compared to a clinical trial in treatment-resistant depression: a matched adjusted indirect comparison
Bjorkholm C; Gannedahl A; Leval A; Rive B; Cars T; Sjalin M; Van Sanden S; Hellner C; Lundberg J
Preprint: BIORXIV. 2020
Low convergent validity of [₁₁C]raclopride binding in extrastriatal brain regions: a PET study of within-subject correlations with [₁₁C]FLB 457
Freiburghaus T; Svensson J; Matheson G; Plavén-Sigray P; Lundberg J; Farde L; Cervenka S
Letter: NEUROIMAGE. 2020;207:116371
In response to the letter "[¹¹C]raclopride and extrastriatal binding to D2/3 receptors"
Svensson JE; Schain M; Plaven-Sigray P; Cervenka S; Tiger M; Nord M; Halldin C; Farde L; Lundberg J
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S172
Treatment resistant depression in Stockholm: Disease burden estimations, treatment trajectories and healthcare consumption from a longitudinal population-based cohort
Lundberg J; Hellner C; Leval A; Sjalin M; Ek M; Gannedahl A; Tiihonen J; Loov SA; Cars T
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S367
Constructing a real-world evidence arm to quantify the placebo effect in a randomized control trial utilizing electronic-medical record depression scales
Leval A; Rive B; Bjorkholm C; Merclin N; Umuhire D; Gannedahl A; Milz R; Hellner C; Lundberg J; Cars T
Preprint: BIORXIV. 2019
Validity and reliability of extrastriatal [11C]raclopride binding quantification in the living human brain
Svensson JE; Schain M; Plavén-Sigray P; Cervenka S; Tiger M; Nord M; Halldin C; Farde L; Lundberg J
Review: PSYCHOPHARMACOLOGY. 2018;235(5):1317-1334
The 5-HT_1B receptor - a potential target for antidepressant treatment
Tiger M; Varnas K; Okubo Y; Lundberg J
Conference publication: EUROPEAN PSYCHIATRY. 2018;48:S291
Predictors of response to electroconvulsive therapy in bipolar depression - A population-based register study
Popiolek K; Brus O; Landen M; Lundberg J; Nordanskog P; Nordenskjold A
Conference publication: NEUROPSYCHOPHARMACOLOGY. 2018;43:S133-S134
Quantification of Norepinephrine Transporter Occupancy of Venlafaxine Extended-Release in Patients With Major Depressive Disorder Using Positron Emission Tomography and Radioligand [18 F]FMeNER-D2
Arakawa R; Stenkrona P; Takano A; Svensson J; Andersson M; Nag S; Asamin Y; Hirano Y; Halldin C; Lundberg J
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2017;27:S741-S742
Social cognition in autism spectrum disorder is associated with brain serotonin transporter availability
Tangen A; Andersson M; Nystrom K; Bolte S; Halldin C; Farde L; Lundberg J; Borg J
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2017;27:S716-S717
A multicenter positron emission tomography study of GABA receptor availability in adults with autism
Andersson M; Horder J; Mendez M; Tangen A; Lundberg J; Gee A; Halldin C; Veronese M; Bolte S; Sementa T; Cash D; Turkheimer F; Mick S; Selvaraj S; Nutt D; Lingford-Hughes A; Howes O; Murphy D; Borg J
Conference publication: NEUROPSYCHOPHARMACOLOGY. 2017;42:S366-S367
Electroconvulsive Treatment of Patients With Major Depressive Episodes may Normalize Dopamine D2 Receptor Binding Potential in the Executive and Limbic Striatum: A Pilot PET Study
Svensson J; Tiger M; Liberg B; Halldin C; Schain M; Farde L; Lundberg J
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2007;17:S82-S83
Gender differences in the 5-HT1A receptor and serotonin transporter in the human brain: a PET study
Jovanovic H; Lundberg J; Cerin A; Karlsson P; Halldin C; Nordstrom AL
Thesis / dissertation: 2006
PET studies of the serotonin transporter in the human brain
Lundberg, Johan
Visa fler

Forskningsbidrag

Randomized controlled trial of the effect of anesthetic dose during electroconvulsive therapy for major depression
Swedish Research Council
1 January 2024 - 31 December 2025
CAPSI - Cancer related major depression treated with a single dose of pslilocybin - a randomised placebo controlled double blind clinical trial
Swedish Research Council
1 January 2023 - 31 December 2026
The effect of psilocybin on depression symptom severity, peripheral biomarkers and synaptic density – a single dose randomized double blind, placebo-controlled phase 2 PET study
Swedish Research Council
1 January 2022 - 31 December 2024
Neuropeptide Y as a novel treatment for major depression - clinical trial, and translational molecular and imaging studies
Swedish Research Council
1 January 2017 - 31 December 2019
Transdisciplinary Synergies to Disclose Complexity in Neurodevelopmental Disorder Etiologies: A Basic Science and Clinical Twin Study ("RATSS")
Swedish Research Council
1 January 2017 - 31 December 2019
Identification of molecular changes related to treatment of major depressive disorder measured with Positron Emission Tomography.
Swedish Research Council
1 January 2014 - 31 December 2016
Identification of molecular changes related to treatment of major depressive disorder measured with Positron Emission Tomography.
Swedish Research Council
1 January 2014 - 31 December 2019

Anställningar

Adjungerad Professor, Klinisk neurovetenskap, Karolinska Institutet, 2022-2026

Examina och utbildning

Docent, Psykiatri, Karolinska Institutet, 2015
MEDICINE DOKTORSEXAMEN, Institutionen för klinisk neurovetenskap, Karolinska Institutet, 2006
Läkarexamen, Karolinska Institutet, 1998

Om mig

Artiklar

Alla övriga publikationer

Forskningsbidrag

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI